Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for postoperative pain relief after prostatectomy
IRCT20230410057871N10Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of erythropoietin in postprocedural pain (CPSP) (3 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoints: Pain at rest, Pain during coughing and 19 more. Started Sep 2025; status: completed.
02
Drugs
erythropoietin
03
Conditions
postprocedural pain (CPSP)
Beyond the preview
Go deeper on IRCT20230410057871N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230410057871N10.